Artificial Intelligence

A new partnership aims to use quantum computing to solve the biggest hurdle for plant-based food: making it taste and feel like the real thing.

A new partnership aims to solve industrial MRO's biggest challenges with flexible, AI-powered robotics designed to augment, not replace, the workforce.

With a $137M war chest, Sidewinder Therapeutics is advancing a new class of ultra-precise cancer drugs aimed at tumors that have long evaded treatment.

A new partnership introduces a hardware and software solution to eliminate manual data entry, bridging the gap between lab instruments and data integrity.

Virtual tutor Cignition wins a major EdTech award, validating its innovative data-driven, collaborative approach that is reshaping K-12 learning.

Blue Faery recognizes two doctors whose groundbreaking research in immunotherapy and targeted drugs has created new standards of care for liver cancer patients.

A new report reveals how data centers are the epicenters of the AI revolution, facing immense pressure to balance explosive growth with sustainability.

A new report reveals how generative AI enables mass fraud, with iOS attacks surging 1,151% and deepfakes now a common threat in corporate video calls.

The Norwegian tech firm is shifting its business model with a new platform designed to tame complex, multi-vendor environments and drive recurring revenue.

New research reveals a 'data trust' crisis is derailing enterprise AI. With 80% of initiatives failing, CISOs are caught between speed and security.

UniX AI's new wheeled robot Panther enters homes, pushing a 'deployment-first' strategy. But this leap raises critical questions about privacy and safety.

The largest World Cup ever brings complex risks. A new guide from Safeture and Riskline offers fans and firms the intel needed to travel safely.

A native probiotic developed in Thailand is shown to reduce harmful toxins in kidney disease patients, offering a new, locally-tailored supportive therapy.

Tech giant HPE secures access to next-gen Wi-Fi 6 and 7 tech via Sisvel's patent pool, a move that validates collaborative IP and speeds innovation.

Former Biosynth CEO Dr. Urs Spitz joins Ribbon Bio, signaling a major push to commercialize its groundbreaking cell-free DNA synthesis platform.

A new report shows AI is elevating UK tech roles, not replacing them, while specialized skills command top global pay amid a persistent talent shortage.

Hemispherian launches a landmark trial for GLIX1, a first-in-class therapy aiming to selectively destroy glioblastoma cells where others have failed.

Configit's upcoming summit highlights how CLM provides the data foundation for manufacturers to master mass customization and successfully deploy AI.

As Hong Kong's ETF market booms, ETF365.com.hk launches to provide transparent data, comparisons, and reviews for the everyday retail investor.

A new alliance between Daiichi Sankyo and ATLATL aims to leverage a unique 'Super Server' model to fast-track novel therapies from Asia to the world.